Page last updated: 2024-09-04

carbodiimides and Alloxan Diabetes

carbodiimides has been researched along with Alloxan Diabetes in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, X; Liang, R; Liu, N; Liu, T; Liu, Y; Shen, Z; Sun, P; Wang, G; Wang, L; Wang, S; Wang, Z; Zou, J1
Dwivedi, P; Gupta, GK; Gupta, PK; Mishra, PR; Sharma, S; Singh, A; Teja, BV; Trivedi, R; Verma, A1
Gibly, RF; Graham, JG; Holland, S; Kaufman, DB; Kheradmand, T; Luo, X; Miller, SD; Shea, LD; Tasch, J; Wang, S; Zhang, X1

Other Studies

3 other study(ies) available for carbodiimides and Alloxan Diabetes

ArticleYear
Ethylenecarbodiimide-fixed splenocytes carrying whole islet antigens decrease the incidence of diabetes in NOD mice via down-regulation of effector memory T cells and autoantibodies.
    Endocrine journal, 2018, Sep-27, Volume: 65, Issue:9

    Topics: Animals; Antigens; Autoantibodies; Carbodiimides; Cross-Linking Reagents; Diabetes Mellitus, Experimental; Down-Regulation; Ethylenes; Female; Immune Tolerance; Islets of Langerhans; Lymphocyte Count; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Inbred NOD; Spleen; T-Lymphocytes, Regulatory; Tissue Fixation

2018
Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin.
    Acta biomaterialia, 2016, Volume: 31

    Topics: Administration, Oral; Alginates; Animals; Caco-2 Cells; Calcium Phosphates; Carbodiimides; Chitosan; Diabetes Mellitus, Experimental; Drug Carriers; Electrolytes; Endocytosis; Flow Cytometry; Fluorescein-5-isothiocyanate; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogen-Ion Concentration; Insulin; Male; Microscopy, Confocal; Microscopy, Fluorescence; Nanoparticles; Particle Size; Rats; Rats, Wistar; Vitamin B 12

2016
Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions.
    Biomaterials, 2011, Volume: 32, Issue:20

    Topics: Animals; Biocompatible Materials; Carbodiimides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Humans; Immune Tolerance; Islets of Langerhans Transplantation; Male; Materials Testing; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Polyglactin 910; Spleen; Tissue Scaffolds; Transplantation, Homologous

2011